Characteristics | Whole cohort | Non-diabetics | DM, all | DM 1 | DM 2 | DM unspecified |
---|---|---|---|---|---|---|
Number of subjects, no., % | 290,306, 100.00% | 266,563, 91.82% | 23,743, 8.18% | 4569, 1.57% | 19,071, 6.57% | 44, 0.02% |
Mean DAH30, days | 24.16 | 24.40 | 21.41 | 21.53 | 21.37 | 18.61 |
31-day-1-year mortality, no., % | 14,191, 4.89% | 11,867, 4.45% | 2324, 9.79% | 451, 9.87% | 1862, 9.76% | 6, 13.64% |
P value, mortality | – | – | < 0.001* | < 0.001* | < 0.001* | < 0.001* |
ASA class 1, % | 29.55% | 32.07% | 1.33% | 2.04% | 1.15% | 2.27% |
ASA class 2, % | 43.71% | 44.22% | 37.97% | 39.88% | 37.56% | 27.27% |
ASA class 3, % | 24.61% | 21.86% | 55.40% | 52.90% | 55.99% | 54.55% |
ASA class 4, % | 2.13% | 1.84% | 5.30% | 5.19% | 5.30% | 15.91% |
Women, % | 55.26% | 56.16% | 45.13% | 45.72% | 44.98% | 54.55% |
Acute surgery, % | 31.09% | 30.84% | 33.91% | 38.52% | 32.80% | 50.00% |
Cancer surgery, % | 21.02% | 20.94% | 21.93% | 15.08% | 23.57% | 13.64% |
Top 3 most common surgery types, % | Orthopedic, 31.65%; abdominal, 19.58%; urologic, 10.15% | Orthopedic, 31.30%; abdominal, 19.77%; urologic, 9.98% | Orthopedic, 35.58%; abdominal, 17.46%; urologic 12.05% | Orthopedic, 36.18%; abdominal, 15.25%; vascular 8.78% | Orthopedic, 35.45%; abdominal, 17.96%; urologic, 12.87% | Orthopedic, 40.91%; abdominal, 11.36%; urologic, 11.36% |
Top 3 most common comorbidities, % | Cardiovascular, 23.87%; arrhythmic, 13.59%; cardiac, 6.66% | Cardiovascular, 19.93%; arrhythmic, 12.12%; lung, 5.78% | Cardiovascular, 68.18%; arrhythmic, 30.02%; cardiac, 19.26% | Cardiovascular, 59.68%; renal, 24.44%; arrhythmic, 24.03% | Cardiovascular, 70.16%; arrhythmic, 31.33%; cardiac, 19.67% | Cardiovascular, 75.00%; renal, 38.64%; arrhythmic or cardiac, 34.09% each |
Age, mean ± SD | 60.13 ± 18.87 | 59.31 ± 19.06 | 69.37 ± 19.06 | 61.82 ± 18.89 | 71.16 ± 19.03 | 68.61 ± 14.49 |